Going Green: The Role of the Green Tea Component EGCG in Chemoprevention.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

34 citing papers in PubMed.

1. Significant anti-myeloma potential of green tea infusion and its component dihydromyricetin.Annals of medicine and surgery (2012) · 2026
   Article
2. A Narrative Review on Unravelling Bacterial-Mediated Carcinogenesis and Possible Alternative Treatment Strategies.BioMed research international · 2026
   Review
3. Anti-cancer Properties of Epigallocatechin-3-gallate (EGCG) and its Signaling Pathways.Current medicinal chemistry · 2025
   Review
4. Targeting Tumor Endothelial Cells by EGCG Using Specific Liposome Delivery System Inhibits Vascular Inflammation and Thrombosis.Cancer medicine · 2024
   Article
5. Invisible Waves, Visible Consequences: Environmental Radiation's Role in Human Fertility.Integrative medicine (Encinitas, Calif.) · 2024
   Review
6. Green Cancer Prevention and Beyond.Cancer prevention research (Philadelphia, Pa.) · 2024
   Review
7. The Content of Bioactive Compounds and Technological Properties of Matcha Green Tea and Its Application in the Design of Functional Beverages.Molecules (Basel, Switzerland) · 2023
   Article
8. Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment.Frontiers in nutrition · 2023
   Review
9. Protective Effects of Green Tea Supplementation against Lead-Induced Neurotoxicity in Mice.Molecules (Basel, Switzerland) · 2022
   Article
10. Periodontal Ligament Fibroblast Cell Viability Following Treatment with Different Concentrations of Green Tea, Aloe Vera and a Mixture of their Extracts.Frontiers in dentistry · 2022
    Article
11. Green Tea Epigallocatechin-3-Gallate Regulates Autophagy in Male and Female Reproductive Cancer.Frontiers in pharmacology · 2022
    Review
12. Tea Ingredients Have Anti-coronavirus Disease 2019 (COVID-19) Targets Based on Bioinformatics Analyses and Pharmacological Effects on LPS-Stimulated Macrophages.Frontiers in nutrition · 2022
    Article
13. Role of Phytochemicals in Cancer Chemoprevention: Insights.Antioxidants (Basel, Switzerland) · 2021
    Review
14. Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention.Nutrients · 2020
    Review
15. Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity.Cells · 2019
    Review
16. Radiations and male fertility.Reproductive biology and endocrinology : RB&E · 2018
    Review
17. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer.Nutrients · 2018
    Review
18. Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.Aging · 2018
    Article
19. Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.Molecular medicine reports · 2018
    Article
20. Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Frontiers in pharmacology · 2018
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

Abstract

Indexed as